Morgan Stanley - Mar 31, 2025 SCHEDULE 13G/A Report for Tarsus Pharmaceuticals, Inc. Common Stock (TARS)

Filing Manager
MORGAN STANLEY
Reporting Manager
Morgan Stanley
Symbol
TARS
Shares outstanding
41.4M shares
Disclosed Ownership
1.94M shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Date filed
5/7/2025, 11:27 AM
Date of event
Mar 31, 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 4.7% 1.94M 0 1.93M Christopher O'Hara Authorized Signatory, Morgan Stanley